Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polonsky

Showing results (91-100 of 951) with videos related to

Pageof 96
Sort By:
Journal of Natural Products|November 1, 1984
15-Deacetylsergeolide, a potent antileukemic quassinoid from Picrolemma pseudocoffeaJ Polonsky, S Bhatnagar, C Moretti
Journal of the American College of Cardiology|October 15, 2021
Finding the Right Age for CAC Testing: How Low Should You Go?Tasneem Z Naqvi, Tamar S Polonsky
Nature|December 14, 2001
Diabetes mellitus and genetically programmed defects in beta-cell functionG I Bell, K S Polonsky
Cell Metabolism|August 16, 2005
Diabetic pancreatic beta cells ARNT all they should beMatteo G Levisetti, Kenneth S Polonsky
Diabetes|May 1, 1984
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitationsK S Polonsky, A H Rubenstein
Immunology and Cell Biology|November 27, 2015
Clonal expansion under the microscope: studying lymphocyte activation and differentiation using live-cell imagingMichal Polonsky, Benjamin Chain, Nir Friedman
Journal of Diabetes Science and Technology|December 16, 2020
Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 DiabetesWilliam H Polonsky, Addie L Fortmann
Journal of Diabetes Science and Technology|May 9, 2022
The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 DiabetesEmily C Soriano, William H Polonsky
Current Opinion in Cardiology|March 15, 2019
Risk factors for chemotherapy-related cardiac toxicityTamar S Polonsky, Jeanne M DeCara
The American Journal of Cardiology|June 14, 2008
Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapyTamar S Polonsky, Michael H Davidson
Pageof 96

Showing results (91-100 of 951) with videos related to

Sort By:
Pageof 96
Journal of Natural Products|November 1, 1984
15-Deacetylsergeolide, a potent antileukemic quassinoid from Picrolemma pseudocoffeaJ Polonsky, S Bhatnagar, C Moretti
Journal of the American College of Cardiology|October 15, 2021
Finding the Right Age for CAC Testing: How Low Should You Go?Tasneem Z Naqvi, Tamar S Polonsky
Nature|December 14, 2001
Diabetes mellitus and genetically programmed defects in beta-cell functionG I Bell, K S Polonsky
Cell Metabolism|August 16, 2005
Diabetic pancreatic beta cells ARNT all they should beMatteo G Levisetti, Kenneth S Polonsky
Diabetes|May 1, 1984
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitationsK S Polonsky, A H Rubenstein
Immunology and Cell Biology|November 27, 2015
Clonal expansion under the microscope: studying lymphocyte activation and differentiation using live-cell imagingMichal Polonsky, Benjamin Chain, Nir Friedman
Journal of Diabetes Science and Technology|December 16, 2020
Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 DiabetesWilliam H Polonsky, Addie L Fortmann
Journal of Diabetes Science and Technology|May 9, 2022
The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 DiabetesEmily C Soriano, William H Polonsky
Current Opinion in Cardiology|March 15, 2019
Risk factors for chemotherapy-related cardiac toxicityTamar S Polonsky, Jeanne M DeCara
The American Journal of Cardiology|June 14, 2008
Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapyTamar S Polonsky, Michael H Davidson
Pageof 96